UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000054148
Receipt number R000061832
Scientific Title Clinical Utility of Computed Tomography Derived Extracellular Volume Fraction in The Patients with Aortic Stenosis: A Meta-analysis
Date of disclosure of the study information 2024/04/15
Last modified on 2024/04/14 17:43:00

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical Utility of Computed Tomography Derived Extracellular Volume Fraction in The Patients with Aortic Stenosis: A Meta-analysis

Acronym

Clinical Utility of Computed Tomography Derived Extracellular Volume Fraction in The Patients with Aortic Stenosis: A Meta-analysis

Scientific Title

Clinical Utility of Computed Tomography Derived Extracellular Volume Fraction in The Patients with Aortic Stenosis: A Meta-analysis

Scientific Title:Acronym

Clinical Utility of Computed Tomography Derived Extracellular Volume Fraction in The Patients with Aortic Stenosis: A Meta-analysis

Region

Japan Asia(except Japan) North America
South America Europe


Condition

Condition

Aortic Stenosis

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Computed tomography-derived extracellular volume fraction (CT-ECV) has emerged as a non-invasive method to quantify myocardial fibrosis. Although many studies suggest the usefulness of CT-ECV, its clinical use remains limited in patients with aortic stenosis. Therefore, we will perform a meta-analysis to clarify the clinical value of CT-ECV.

Basic objectives2

Others

Basic objectives -Others

The prognostic value of ECV will also be examined.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Electronic database searches will use PubMed, Web of Science Core Collection, and EMBASE. To evaluate the prognostic value of CT-ECV in aortic stenosis.

Key secondary outcomes



Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The following search formulas will be used for the literature obtained.
#1 computed tomography OR CT
#2 extracellular volume OR ECV OR CT-ECV
#3 aortic stenosis OR AS
#4 #1 AND #2 AND #3

Key exclusion criteria

We will exclude references that are unbeatable for our analysis, such as those with missing data.

Target sample size



Research contact person

Name of lead principal investigator

1st name Jin
Middle name
Last name Kirigaya

Organization

Yokohama City University Medical Center

Division name

Division of Cardiology

Zip code

2320024

Address

4-57 Urafunacho, Minami-ku, Yokohama City, Kanagawa Prefecture

TEL

0452615656

Email

kirigaya@yokohama-cu.ac.jp


Public contact

Name of contact person

1st name Jin
Middle name
Last name Kirigaya

Organization

Yokohama City University Medical Center

Division name

Division of Cardiology

Zip code

232-2202

Address

4-57 Urafunacho, Minami-ku, Yokohama City, Kanagawa Prefecture

TEL

0452615656

Homepage URL


Email

kirigaya@yokohama-cu.ac.jp


Sponsor or person

Institute

Yokohama City University

Institute

Department

Personal name

Jin Kirigaya


Funding Source

Organization

Yokohama City University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

IRB of Yokohama City University Medical Center

Address

4-57 Urafunacho, Minami-ku, Yokohama City, Kanagawa Prefecture

Tel

0452615656

Email

kirigaya@yokohama-cu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 04 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

1004

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2024 Year 04 Month 14 Day

Date of IRB

2024 Year 04 Month 14 Day

Anticipated trial start date

2024 Year 04 Month 14 Day

Last follow-up date

2024 Year 04 Month 14 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Perform meta-analysis in accordance with the protocol.


Management information

Registered date

2024 Year 04 Month 14 Day

Last modified on

2024 Year 04 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000061832


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name